Background
==========

Osteogenesis imperfecta (OI) is a heritable connective tissue disorder, caused by abnormalities in type 1 collagen, and is characterized by bone fragility and other extraskeletal features, including hearing loss, blue sclerae, dentinongenesis imperfecta and hyperlaxity of the ligaments and skin \[[@B1]\]. Patients with OI show a wide range of clinical severities from being nearly asymptomatic, with individuals leading a normal life, to being severe, with individuals showing bone and connective tissue deformities resulting in perinatal death \[[@B2]\].

OI can cause diverse vascular complications such as aortic and carotid artery dissection, cardiac valvulopathy and coronary artery aneurysms \[[@B3]-[@B7]\]. It has been reported that the collagen type 1 alpha-2 gene (*COL1A2*) may predispose patients to intracranial aneurysms (IAs) \[[@B8]\], and that the cerebrovascular system is less frequently involved in OI. We report the case of a patient in whom OI was diagnosed following subarachnoid hemorrhage (SAH) secondary to a ruptured intracranial saccular aneurysm.

Case Presentation
=================

A 37-year-old woman was referred to our hospital because of sudden headache and vomiting. She had no family history of aneurysms. Neurologic examination revealed slight disturbance of consciousness (Glasgow Coma Scale score, 14) and neck stiffness without any focal deficit. Brain computed tomography (CT) showed diffuse SAH (Fisher stage 3) and an arachnoid cyst of the right middle fossa (Figure  [1](#F1){ref-type="fig"}). Subsequent cerebral digital subtraction angiography (DSA) indicated a saccular aneurysm of the middle cerebral artery (Figure  [2](#F2){ref-type="fig"}). Because of the ruptured IA, a diagnosis of SAH (World Federation of Neurosurgical Society grade 2) was made. The patient had blue sclerae (Figure  [3](#F3){ref-type="fig"}), hypertension, and mitral regurgitation (New York Heart Association class 2), and had sustained repeated fractures of the extremities such as left elbow joint and left ankle joint prior to puberty. Her height was 158 cm (equal to the average height of Japanese women) with no major skeletal deformities. The patient's son also had blue sclerae and a history of multiple fractures; however there was no history of bone fragility in her parents, two brothers or daughter. According to these findings, the diagnosis of OI type 1A was made during admission \[[@B9]\].

![Computed tomography scan of the brain on arrival at the hospital, indicating diffuse subarachnoid hemorrhage and an arachnoid cyst at the right middle fossa.](1471-2377-14-150-1){#F1}

![**Preoperative cerebral digital subtraction angiography showing a right middle cerebral artery aneurysm (5 mm in diameter). (A)** Right internal carotid angiography in the anteroposterior direction. **(B)** Three-dimensional angiography.](1471-2377-14-150-2){#F2}

![Photograph of the patient's eyes, showing typical blue sclerae.](1471-2377-14-150-3){#F3}

Surgical clipping of the aneurysm was performed, and the patient was asymptomatic after one week. Follow-up DSA demonstrated a completely clipped aneurysm (Figure  [4](#F4){ref-type="fig"}). The patient underwent rehabilitation and was discharged from the hospital four weeks after admission.

![**Postoperative cerebral digital subtraction angiography showing a right middle cerebral artery aneurysm that has been successfully clipped. (A)** Right internal carotid angiography in the anteroposterior direction. **(B)** Three-dimensional angiography.](1471-2377-14-150-4){#F4}

The patient's left femoral bone density was 0.752 g/cm^2^, which was in the Japanese female average. We also measured levels of serum bone metabolism markers, and they were within normal limits found in adult women; pyridinoline cross-linked carboxyterminal telopeptide of type I collagen, 1.1 ng/mL (normal range, \<4.5); intact amino-terminal propeptide of type I procollagen, 16.6 μg/L (normal range, 14.9-68.8); tartrate-resistant acid phosphatase-5b, 147 mU/dL (normal range, 120--420); osteocalcin, 10 ng/mL (normal range, 2.5-13); and bone-specific alkaline phosphatase, 9.2 μg/L (normal range, 2.9-14.5).

We performed genetic analysis for a single nucleotide G/C polymorphism (SNP) of exon 28 of the *COL1A2* gene, which was reported as a potential risk factor for IAs \[[@B8]\]. However, this SNP was not detected in this patient or five normal control subjects (Figure  [5](#F5){ref-type="fig"}). And no mutation of the *COL1A1* or *COL1A2* gene was detected with genetic analyses.

![**Results for determining a single nucleotide G/C polymorphism (SNP) of exon 28 of the gene encoding for alpha-2 polypeptide of collagen 1 in the patient (upper panel) and one of normal control subjects (lower panel).** The SNP28 of COL1A2 was not detected in any of them.](1471-2377-14-150-5){#F5}

Discussion
==========

The diagnosis of OI is based mainly on clinical signs, symptoms, and positive family history \[[@B10]\]. Most patients with OI have a mutation of either the *COL1A1* or *COL1A2* gene, which are the two genes that code for alpha-1 and alpha-2 chains of type 1 collagen, respectively. More than 2,000 different type 1 collagen mutations have been identified in patients with OI and are listed in a database \[[@B11],[@B12]\]. Type 1 collagen is the most abundant connective tissue in the vertebrate and is found in other tissues, including blood vessels \[[@B13]\]. Interstitial type 1 collagen was reported to be deposited on the surfaces of smooth muscle cells or along elastin filaments in the cerebrovascular wall, and thus, type 1 collagen might play a role in the rigidity and elasticity of the vascular wall. We did not identify any known mutation in *COL1A1* or *COL1A2* in our patient. However, OI was directly diagnosed in this patient because of the presence of bone fragility, extraskeletal features, including blue sclerae and mitral regurgitation, and a positive family history, despite her normal bone density and normal bone metabolism markers. The association between OI and an intracranial arachnoid cyst is also known \[[@B14]\], similarly as demonstrated in brain CT scan of this patient.

Yoneyama et al. \[[@B8]\] reported the association between the functional variant SNP28 of *COL1A2* and Japanese familial IA. However, in that study, SNP28 was observed in only 10.4% of total IAs (n = 260) and 5.5% of control subjects (n = 291). Although SNP28 was not detected in our patient and normal control subjects, we consider these results as acceptable regarding low prevalence of the SNP. Meanwhile, most of the vascular complications in patients with OI have been reported as artery dissections \[[@B3]-[@B7]\]. A few sporadic case reports described intracranial artery dissections complicated by OI \[[@B15],[@B16]\].

To our knowledge, SAH secondary to ruptured IA in patients with OI has been reported in only six cases (Table  [1](#T1){ref-type="table"}) \[[@B17]-[@B22]\]. Three case reports have described patients with a saccular anterior communicating artery aneurysm \[[@B17]-[@B19]\], and another described a patient with a saccular aneurysm at a fenestrated basilar artery \[[@B20]\]; this is the only case report of SAH in a patient with OI in whom the SNP28 of the *COL1A2* gene was detected. The fifth report described a patient with a ruptured dissecting-type pseudoaneurysm at the right superior cerebellar artery \[[@B21]\]; this is the only case in which SAH secondary to an intracranial artery dissection was reported. The sixth and most recent report described a patient with a saccular aneurysm of the vertebral artery \[[@B22]\]. It is difficult to determine whether ruptured, in particular saccular, IAs are truly caused by OI or accidentally complicated by OI.

###### 

Case reports of subarachnoid hemorrhage secondary to ruptured intracranial aneurysm with osteogenesis imperfecta

   **Authors (year)**                         **Age, Sex**   **Location**   **Shape**                   **Supplement**
  ------------------------------------------ -------------- -------------- ------------ ---------------------------------------------
  Okamura T, et al. (1995) \[[@B17]\]             33 F         A-com A       Saccular                  VA fenestration
  Narváez J, et al. (1996) \[[@B18]\]             22 F         A-com A       Saccular                          
  Havlik DM, et al. (2006) \[[@B19]\]             38 M         A-com A       Saccular                          
  Petruzzellis M, et al. (2007) \[[@B20]\]        44 M         VA union      Saccular    SNP28 of *COL1A2*: detected VA fenestration
  Matouk CC, et al. (2011) \[[@B21]\]             49 M           SCA        Dissection                         
  Kaliaperumal C, et al. (2011) \[[@B22]\]        53 M            VA         Saccular                          
  Our case (2013)                                 37 F           MCA         Saccular          SNP28 of *COL1A2*: not detected

*SAH*; subarachnoid hemorrhage, *F*; female, *M*; male, *A-com A*; anterior communicating artery, *VA*; vertebral artery, *SCA*; superior cerebellar artery, *MCA*; middle cerebral artery.

Conclusion
==========

We described a case of SAH secondary to ruptured saccular intracranial aneurysm in a 37-year-old female patient with clinically diagnosed OI. She was successfully treated with the surgical neck clipping of the aneurysm. Although no mutation in the *COL1A1* or *COL1A2* gene was detected, it is obvious that this patient is clinically OI. There may be some causative relationship between OI and SAH because there are several reported cases of SAH secondary to cerebral aneurysm in patients with OI.
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